Editas Medicine Inc.

1.42
0.01 (0.71%)
At close: Jan 28, 2025, 2:39 PM

Editas Medicine Statistics

Share Statistics

Editas Medicine has 82.55M shares outstanding. The number of shares has increased by 0.9% in one year.

Shares Outstanding 82.55M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.09%
Owned by Institutions (%) n/a
Shares Floating 81.78M
Failed to Deliver (FTD) Shares 3
FTD / Avg. Volume 0%

Short Selling Information

The latest short interest is 16.93M, so 20.51% of the outstanding shares have been sold short.

Short Interest 16.93M
Short % of Shares Out 20.51%
Short % of Float 20.7%
Short Ratio (days to cover) 5.91

Valuation Ratios

The PE ratio is -5.02 and the forward PE ratio is -1.31.

PE Ratio -5.02
Forward PE -1.31
PS Ratio 9.85
Forward PS 16.6
PB Ratio 2.2
P/FCF Ratio -5.62
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Editas Medicine Inc. has an Enterprise Value (EV) of 682.42M.

EV / Earnings -4.45
EV / Sales 8.74
EV / EBITDA -4.18
EV / EBIT -4.03
EV / FCF -4.98

Financial Position

The company has a current ratio of 5.39, with a Debt / Equity ratio of 0.1.

Current Ratio 5.39
Quick Ratio 5.39
Debt / Equity 0.1
Total Debt / Capitalization 9.47
Cash Flow / Debt -3.62
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -0.44% and return on capital (ROIC) is -43.87%.

Return on Equity (ROE) -0.44%
Return on Assets (ROA) -0.31%
Return on Capital (ROIC) -43.87%
Revenue Per Employee 294.80K
Profits Per Employee -578.18K
Employee Count 265
Asset Turnover 0.16
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -81.52% in the last 52 weeks. The beta is 2.01, so Editas Medicine 's price volatility has been higher than the market average.

Beta 2.01
52-Week Price Change -81.52%
50-Day Moving Average 1.76
200-Day Moving Average 3.85
Relative Strength Index (RSI) 47.97
Average Volume (20 Days) 2.75M

Income Statement

In the last 12 months, Editas Medicine had revenue of 78.12M and earned -153.22M in profits. Earnings per share was -2.02.

Revenue 78.12M
Gross Profit -99.53M
Operating Income -169.18M
Net Income -153.22M
EBITDA -163.12M
EBIT -169.18M
Earnings Per Share (EPS) -2.02
Full Income Statement

Balance Sheet

The company has 123.65M in cash and 36.54M in debt, giving a net cash position of 87.12M.

Cash & Cash Equivalents 123.65M
Total Debt 36.54M
Net Cash 87.12M
Retained Earnings -1.23B
Total Assets 327.57M
Working Capital 198.79M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -132.18M and capital expenditures -4.72M, giving a free cash flow of -136.90M.

Operating Cash Flow -132.18M
Capital Expenditures -4.72M
Free Cash Flow -136.90M
FCF Per Share -1.8
Full Cash Flow Statement

Margins

Gross margin is -127.4%, with operating and profit margins of -216.56% and -196.13%.

Gross Margin -127.4%
Operating Margin -216.56%
Pretax Margin -196.13%
Profit Margin -196.13%
EBITDA Margin -208.8%
EBIT Margin -216.56%
FCF Margin -175.23%

Dividends & Yields

EDIT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -143.26%
FCF Yield -117.7%
Dividend Details

Analyst Forecast

The average price target for EDIT is $7.5, which is 431.9% higher than the current price. The consensus rating is "Hold".

Price Target $7.5
Price Target Difference 431.9%
Analyst Consensus Hold
Analyst Count 14
Stock Forecasts

Scores

Altman Z-Score -6.98
Piotroski F-Score 2